Access the profiles of the more than 350 Lowenstein Sandler lawyers who provide critical legal counsel to clients in virtually every sector of the global economy...
Discover the latest updates and developments about Lowenstein Sandler...
Access our insightful thought leadership, including articles, client alerts, and blog posts...
Mergers and acquisitions are often key components of the growth strategies implemented by some of today's most successful companies. Such an approach requires legal capabilities that are flexible, broad-based, and capable of optimizing capital and speed.
Our Mergers & Acquisitions Lawyers in our Practice Group represents major corporations and private equity sponsors as they plan and execute a broad range of strategic acquisitions and dispositions. Team lawyers also regularly guide young, entrepreneurial companies through cutting-edge deals–from formation and funding to IPOs and ultimate sales. We also often assist non-U.S.-based law firms in significant cross-border transactions.
Our versatility is the product of a firm culture that is creative, proactive, and passionately dedicated to client service. Like our clients, we take the long view, striving to build collaborative relationships based on a shared understanding of business goals.
Chambers USA consistently recognizes us for our ability to handle transactions and mergers in all industries: "There is no question that they are a standout corporate/M&A firm" and "a corporate powerhouse with great depth of practice."
Our clients benefit from access to the resources, knowledge, and experience of the entire firm. Key members of our team accelerate clients' strategic success through Lowenstein Sandler's Transactions & Advisory Group (TAG). This collaborative unit offers clients an integrated legal solution for executing transactions and managing related corporate governance and compliance issues.
Additionally, several of the firm's nationally recognized complementary practices help sharpen our edge–and contribute to our record of success–in M&A transactions:
Clients call on us for strategic counsel on the most effective financing strategies to fund acquisitions.
In cases of divestiture, we focus on ensuring deal certainty, reducing post-closing exposure, and bringing innovative solutions to close on the most advantageous terms possible for our clients. Through in-depth analysis, strategic planning, and assertive negotiation, we help clients divest of nonessential capabilities or unprofitable subsidiaries, leverage the resources and security offered by a larger company, or cash out of the business entirely.
Represented Foley, Inc., the Caterpillar franchisee for northern New Jersey, Staten Island, and Bermuda, in its acquisition of substantially all assets of Giles & Ransome, Inc.
Represented FTP Power LLC (sPower), the largest independent owner, operator, and developer of utility scale solar assets in the United States, in its $2.1 billion sale to affiliates of The AES Corporation and Alberta Investment Management Corporation by Fir Tree Partners and sPower’s minority owners.
Represented The Estée Lauder Companies Inc. in its $1.45 billion acquisition of Too Faced, one of the fastest growing makeup brands in the specialty-multi and online categories.
Represented Diligent Corporation (NZX:DIL), the leading provider of secure online collaboration and document sharing solutions for boards, committees and leadership teams, in its acquisition by Insight Venture Partners, a leading global venture capital and private equity firm.
Represented BASF Corporation in its acquisition of Zed X, Inc., a leader in the development of digital agricultural intelligence.
Represented Aceto Corporation (NASDAQ:ACET) in its $462 million acquisition of the generic drug-related assets of Citron Parma LLC and its affiliate, Lucid Parma LLC.
Represented Yodle, Inc., a leader in cloud- based marketing solutions, in its acquisition by Web.com Group, Inc.
Represented Pamplona Capital Management and Beacon Rail Leasing in the sale of Beacon Rail to institutional investors advised by JPMorgan Asset Management.
Represented Medical Specialties Distributors, LLC, a New Mountain Capital portfolio company, in its acquisition of Attentus Medical Sales.
Represented Vesey Street Capital Partners (VSCP), as part of the recapitalization of HealthChannels, the parent company of ScribeAmerica. VSCP, a strategic private equity firm dedicated to healthcare services investments, led the recapitalization alongside HealthChannels’ management team.
Represented InSite Wireless Group, LLC in connection with Macquarie Infrastructure Partners III’s $280 million equity investment in InSite Wireless Group, LLC.
Representing Hildred Capital Partners, LLC, a private investment firm formed by Howard Solomon and David Solomon, in its pending major stake investment in Crown Laboratories, Inc.
Representing Liberty Street Advisors, and its affiliates, HRC Portfolio Solutions, and HRC Fund Associates, in the sale of certain assets to Brookfield Asset Management’s Public Securities Group, a leading global alternative asset manager with approximately $250 billion of assets under management.
Representing Indorama Ventures Public Company Limited (BKK:IVL) as co-counsel with Allen & Overy in its pending acquisition of DuPont Teijin Films. Lowenstein is leading the US components of the acquisition.
Represented EarthColor in its sale to Mittera Group, Inc., a multi-platform print, marketing and media company.
Represented Pamplona Capital Management in connection with its preferred equity financing of Bass Pro Shop in connection with its acquisition of Cabela’s Incorporated (NYSE: CAB).
Represented AMP Capital in connection with the acquisition of a minority stake in United Capital.
Represented Vesey Street Capital Partners in the sale of Imedex, LLC to HMP Communications Holdings, LLC.
Represented Pamplona Capital Management in connection with the sale of Spreemo, Inc. to One Call Care Management.
Represented Cancer Genetics, Inc. (Nasdaq: CGIX) in connection with its $12 million acquisition of vivoPharm Pty. Ltd.
Represented Versum Materials, Inc. (NYSE: VSM) in connection with its acquisition of Dynaloy LLC, a wholly owned subsidiary of Eastman Chemical Company (NYSE: EMN).
Represented Bowlmor AMF Corp.’s board of directors in the sale of the majority of the capital stock of Bowlmor AMF Corp. to Atairos Group, Inc.
Represented The Estée Lauder Companies Inc. (NYSE: EL) in its investment in DECIEM.
Represented Abacus Group, LLC in the sale of a minority stake in Abacus Holdings I, LLC to WestView Capital Partners.
Represented Hausmann Industries Inc. in its sale to Dynatronics Corporation.
Represented Holmdel Pharmaceuticals LP and Cranford Pharmaceuticals, LLC in the sale of InnoPran XL and Inderal XL, respectively, to ANI Pharmaceuticals, Inc. (Nasdaq: ANIP)
Represented Floored in its sale to CBRE Group, Inc. (NYSE: CBG).
Represented Gravitas Technology Services, LLC in its sale to Linedata Services S.A.
Representing Indorama Ventures Public Company Limited (BKK:IVL) as co-counsel with Allen & Overy in its pending acquisition of DuPont Teijin Films. Lowenstein is leading the US components of the acquisition.
Represented Versum Materials (NYSE: VSM) in connection with its acquisition of Dynaloy, LLC, a wholly owned subsidiary of Eastman Chemical Company.
Represented Topix Pharmaceuticals, a New Mountain Capital portfolio company and independent leader in skincare products, in connection with the acquisitions of Derma E and Clarity Clinical Skin Care, Inc. (dba “ClarityRx”), two rapidly growing California-based natural skincare companies.
We are representing Aravive Biologics, Inc., as co-counsel, in its pending merger with a wholly owned subsidiary of Versartis, Inc. (Nasdaq:VSAR) in an all-stock transaction.
Represented Revint Solutions, a New Mountain Capital portfolio company and industry leader in revenue recovery and consulting services to the healthcare industry, in connection with the acquisition of each of AcuStream, a revenue assurance specialty company dedicated to the healthcare industry, and CloudMed, a revenue assurance company specializing in the inpatient coding and documentation side of the healthcare revenue cycle.
Represented Indorama Ventures Public Company Limited (BKK:IVL) as co-counsel with Mattos Filho in its acquisition of M&G Polimeros Brazil S.A., owner of Brazil’s largest PET (polyethylene terephthalate) facility.
Represented Indorama Ventures Corpus Christi Holdings LLC (subsidiary of Indorama Ventures Public Company Limited) in a joint venture between Indorama Ventures Corpus Christi Holdings LLC, DAK Americas, LLC (a subsidiary of the chemicals manufacturer Alpek S.A.B. de C.V. (BMV: ALFAA)), and APG Polytech USA Holdings, Inc. (a subsidiary of Far Eastern New Century Corporation (TT: 1402)), in the acquisition, through a bankruptcy auction, of a Corpus Christi, Texas-based PTA-PET plant from M&G USA Corp. (a subsidiary of M&G Chemicals), for a purchase price and capital contributions in the sum of $1.125 billion.
Represented Compassionate Care Hospice, a community-based organization providing hospice care nationwide, in its $340 million sale to Amedisys, Inc. (NASDAQ: AMED). This transaction makes Amedisys the third largest hospice provider in the U.S.
Represented TRANZACT, and its executive management team, a provider of comprehensive, direct-to-consumer sales and marketing solutions for leading insurance carriers in the United States, in its $1.4 billion sale to Willis Towers Watson, a leading global advisory, broking and solutions company. (July 2019)
Represented Aceto Corporation, an international company engaged in the development, marketing, sale and distribution of human health products, pharmaceutical ingredients and performance chemicals, in the $411 million sale of its chemical business assets, plus the payment of cure costs and the assumption of certain liabilities, to an affiliate of New Mountain Capital, LLC, and in the $137 million sale of its pharmaceutical business assets, including the payment of cure costs and the assumption of certain liabilities, to an affiliate of Suven Life Sciences Limited and Shore Pharma Investments, LLC, each through a Court-supervised process under Section 363 of the Bankruptcy Code. (April 2019)
Represented Ethoca, a global provider of technology solutions that help merchants and card issuers collaborate in real-time to quickly identify and resolve fraud in digital commerce, in its acquisition by Mastercard (NYSE: MA). (April 2019)
Represented Cambium Learning Group, Inc. (Nasdaq: ABCD), a leading SaaS educational technology solutions company, in its $900 million acquisition by Veritas Capital, a New York-based private-equity firm. (December 2018)
Represented Cambium Learning Group, Inc. (Nasdaq: ABCD), ), a leading SaaS educational technology solutions company, in its acquisition of VKidz Holdings Inc., an educational technology company delivering comprehensive online curriculum for PreK through 12th grade students. (December 2018)
Represented Vesey Street Capital Partners, LLC, a private equity firm dedicated to middle market health care services investments, in its acquisition of Elite Body Sculpture, a leading provider of minimally invasive body sculpting procedures. (October 2018)
Represented Regulatory Professionals, Inc., a global integrated regulatory outsourcing providers to the pharmaceutical, biopharmaceutical, and medical device industries, in its acquisition by Premier Research, a global provider of clinical development services to biopharmaceutical product innovators. (July 2018)
Represented Fenway Partners in its acquisition of Iconic Group, provider of photography services at university and college graduations. (August 2018)
Represented Refresh Club, Inc., d/b/a The Wing, in a $32 million Series B round led by Bird InvestCo LLC, a wholly-owned subsidiary of WeWork Companies Inc., and with participation from New Enterprise Associates, 15 L.P. (November 2017)
Represented the founder in connection with the sale of Exhale Spa to Hyatt Hotels. Exhale Spa has 25 locations, both free-standing and in hotels, throughout the United States and the Caribbean. (August 2017)
Represented founder and management team in Radwell International, Inc.’s recapitalization transaction with CVC Capital Partners VIII. Radwell International stocks and sells new and surplus industrial automation, MRO, pneumatic, motion, electronic, hydraulic, HVAC and electrical control equipment for plant floor and facilities maintenance machinery.
Served as US counsel to Indorama Ventures Public Company Limited (BKK:IVL) in its $1.3 billion acquisition of Brazil-based Oxiteno S.A. Indústria e Comércio, a subsidiary of Ultrapar Participações S.A.
Meredith Beuchaw and Ed Zimmerman of Lowenstein’s Tech Group provide input on best practices and considerations for startup founders in the M&A process in an article in TechCrunch by Vishal Lugani, general partner and co-founder at Acrew Capital. The article provides a suggested timeline to accommodate the need for startups to build relationships with potential acquirers, comply with governance requirements, conduct due diligence, and negotiate key deal terms; it also recommends the best way to choose an acquirer, reach consensus among stakeholders, manage legal issues, and maintain momentum towards closure. (subscription required to access article)
Steven E. Siesser, partner, Chair of Lowenstein’s Private Equity practice and Co-Chair of the Transactions & Advisory Group, comments in The Deal on the current scrutiny private equity firms are receiving from Washington for their M&A strategies and the time-tested tactic they are using to cross the finish line: withdrawing and resubmitting transaction paperwork to federal enforcers. Siesser notes that, while the government is “looking at filings more intensely” and is “making it harder to get the deals done,” the pull-and-refiles “are definitely up,” from his perspective, but it’s “not a big number.” (subscription required to access article)
Steven E. Siesser, Chair of Lowenstein’s Private Equity and Co-Chair of its Transactions & Advisory Group, tells CFO Dive that it is likely Elon Musk will make changes to Twitter’s board if he acquires the company. Siesser notes that “partially private-equity backed acquirers similar to the Musk-led group … typically make changes at the board level as the deal closes but may take time, months to a few years, to evaluate the top executives,” adding that those who don’t agree with the new owner’s mission may not last long.
The Global Legal Chronicle covers Lowenstein’s role representing PJW Restaurant Group, an American restaurant holding company with 26 restaurants and six different brands throughout Southern New Jersey and Eastern Pennsylvania, in its sale to Garnett Station Partners. The deal team was led by Nicholas San Filippo IV.
In Bisnow, Steven E. Siesser, Chair of the firm’s Private Equity group and Co-chair of its Transactions & Advisory Group, discusses the hot market for commercial real estate among brokerages, REITs, and private equity firms due to low-interest rates, rising valuations, and investors’ stockpiles of cash. Siesser says, “There's a ton of money out there, valuations are through the roof, the debt markets are wide open. There’s tremendous activity.”
Steven E. Siesser, Chair of the firm’s Private Equity practice and Co-Chair of the Transactions & Advisory Group, comments in Bloomberg Law on the Federal Trade Commission’s recent announcement that it can no longer review mergers and acquisitions within 30 days, as required by the Hart-Scott-Rodino Act; due to the high volume of deals lately, now an investigation may remain open and then subsequently be declared unlawful. “There is no indication of if and when the FTC will tell you the deal is good to go,” Siesser says. “And that leaves you in limbo, which is a real problem because it is an open-ended risk situation.” He adds that this may result in parties being less willing to close deals, requiring contractual changes to mitigate risk of possible future unwinding: “That’s a big deal and a matter of meaningful impact to M&A practitioners already looking to close mergers and acquisitions at a time when activity is so robust, and it’s just such volume in the market.”
Lowenstein's representation of PeriGen Inc. (PeriGen), a leading provider of perinatal health care software solutions, in its sale to Halma plc is noted in the Global Legal Chronicle. The Lowenstein deal team includes Sam E. Khan, Christopher C. Henry, Rachel Ingwer, Lauren M. Troeller, Diana Kim, Kimberly E. Lomot, Megan Monson, Taryn E. Cannataro, Eric Jesse, Bryan Sterba, Matthew P. Hintz, David Toma, James C. Shehan, Edgar R. Hidalgo CIPP/US, Mark S. Heinzelmann, Emily B. Sklar, Megan Williams, Latoya Bethune, and Amanda Sewanan. View Lowenstein's news announcement about this transaction.
In an interview with Authority Magazine, Meredith Beuchaw and Chandra Shih talk about their work in the technology sector, what has influenced them, and why it is important to increase the number of women founders in this field. Beuchaw says, “We’re missing half the great ideas if women are not founding companies and getting funded. We need women because we are missing out on innovation if we do not have women-founded companies.” Shih adds: “Getting more women funded and seeing more women succeed will create a domino effect — it’s the whole idea that representation matters.”
Both Shih and Beuchaw are members of Lowenstein Sandler’s Tech Group, known for representing the underrepresented. Shih, who works with growth stage and early stage startups as well as venture firms and other angel and strategic investors, talks about having been recruited and mentored by her former law school professor and managing partner of the firm’s Palo Alto office, Kathi Rawnsley: “In addition to enjoying the work we do and the people I get to work with, it has been so fantastic to start and grow my career at a place where I could see women had a seat at the table at the highest levels of the firm."
When asked to name her influences, Beuchaw, who leads M&A transactions and has counseled clients both on the buy and sell side through hundreds of deals for over 15 years, cites Michelle Obama’s quote, “When they go low, we go high.” “It is about not letting others’ poor behavior be an excuse for our own,” she says. “This is especially important as we see more women on boards and in decision-making positions. Sadly, most of us have been at the received end of bad behavior along the way, but it is important not to let that be the standard for our behavior now and realize we can bring our moral high ground with us."
Shih references Stacey Abrams’ book, Lead from the Outside, as a helpful guide that "focuses on the challenges that women, people of color and those in the LGBTQ community might have in starting their career, as they are told, ‘to advance you must be a leader,’ but may not know where to begin because the system they’re trying to advance in was not built for them.”
Ed Zimmerman, Chair and co-founder of The Tech Group, Adjunct Professor of Venture Capital at Columbia Business School, and a Founding Partner of First Close Partners LLC, speaks about The Diversity Dividend (#ElDividendodelaDiversidad) as part of a panel, “The Return on Investing in Diverse Fund Managers,” presented by Promoting Venture Capital in Peru (PECAP). The panel, including Susana Garcia-Robles of Capria/LAVCA, Anita Fiori of IDB Lab, Jose Fernandez of StepStone Group, and moderator Luis Narro of PECAP, addresses why it is important and lucrative to invest in underrepresented venture capital fund managers. “Diversity is not only an imperative from a human rights, civil rights, and justice perspective, … it is a financial imperative,” Zimmerman says. “There are unbelievable missed economic opportunities as a result of the myopia that comes from having only people who look the same, went to the same schools, and live in the same communities.” He encourages LPs to speak up by asking GPs to diversify their reference list in order to expose the flaws in their networks. Zimmerman notes that a lack of diversity in the VC world results in “massive costs and causes exclusion, discomfort, and inequity in the workplace.”
Nicholas San Filippo IV is interviewed on the Deep Wealth: The Sell My Business Podcast, where he discusses proven strategies for achieving successful M&A deals. San Filippo talks about common mistakes business owners make, the impact of the COVID-19 pandemic, and why trust is the currency in mergers and acquisitions. San Filippo also explains why he became an M&A lawyer: “I feel like Superman when I come in and I'm able to help entrepreneurs go from paper wealth to liquid wealth."
In Bloomberg Wealth, partner Steven E. Siesser, Chair of Lowenstein’s Private Equity practice and Co-chair of its Transactions & Advisory Group, cautions about the unpredictable future of now-popular special purpose acquisition companies (SPACS): “Whatever stops this bull market will lay its first sights on SPACs,” he says. “They'll be the first casualty.”
On GGV Capital’s Unscripted, Ed Zimmerman, Chair and co-founder of The Tech Group and Adjunct Professor of Venture Capital at Columbia Business School, talks to GGV’s Jeff Richards about the importance of QSBS for founders, diversity on your startup’s board, the leverage shift in term sheet negotiations, and the impact of SPACs v. IPOs for VC-backed growth companies.
Lowenstein's representation of NextWave HoldCo LLC (NextWave) in the company's signing of a new $200 million senior secured first lien term loan facility provided by Canyon Partners, LLC, is noted in the Global Legal Chronicle and Business Wire. The Lowenstein team included Marita A. Makinen, Michael A. Buxbaum, Lowell A. Citron, Michael Walutes, Jacob D. Unger, and Matthew Tippy. View Lowenstein's news announcement about this transaction.
Lowenstein's news announcement, Anticipated Spike in Deal Activity in 2021 Makes Customized R&W Insurance Critical, Finds Lowenstein Sandler, is noted in Business Wire, About You, Asia Insurance Review, Benzinga, Financial Content, Insurance Daily News, Mainframe Consulting, MarketWatch, Morningstar, Seeking Alpha, StreetInsider.com, Yahoo! Finance, Pharma Trend, and Craft.
Lowenstein's representation of longtime client InSite Wireless Group, LLC in its definitive agreement to be acquired by American Tower Corporation (NYSE: AMT) is noted in StreetInsider.com, The Deal, Reuters (November 5, 2020: 1; November 5, 2020: 2), Westlaw Today, Law360 (November 5, 2020; November 6, 2020), citybizlist, Netscape, the Global Legal Chronicle, ICLG, and Business Wire. Lowenstein has represented InSite on a number of transactions, most recently in its acquisition of Repeater Communications Group, LLC. The Lowenstein deal team included Michael A. Brosse, Eugene R. Cheval, Traci M. Tomaselli, Eric Swartz, Sabrina Cua, Timothy J. Nichols, Michael Walutes, Megan Monson, Darren Goodman, Jeffrey Blumenfeld, Lowell A. Citron, Marc S. Kurzweil, Andrew E. Graw, Nicholas G. Mehler, Jeffrey M. Shapiro, Julie Levinson Werner, Norman Spindel, Jack Sidorov, and Matthew P. Hintz. View Lowenstein's news announcement about this transaction.
Rossie E. Turman III explains to The American Lawyer his reasons for moving from Skadden to Lowenstein Sandler as partner and Chair of Lowenstein Sandler’s International Finance group, with seats in the firm’s Debt Financing group and The Tech Group: “If you’re trying to grow, align yourself with someone else that is trying to grow. … [I]f you’re trying to succeed, align yourself with someone else that is trying to succeed.” The article notes that Turman “will work closely with the firm’s Tech Group in representing companies based in emerging markets that have interests in the U.S.” He will lead Lowenstein’s efforts with respect to companies and funds located in and doing business with Africa. He has also actively engaged in civic endeavors and supported several charities on the African continent for nearly 30 years.
In Westlaw Today’s story about his joining the firm, Turman says his “move to Lowenstein would facilitate building out the ‘three-legged stool’ of … [my] … practice, incorporating cross-border transactions, finance and technology.”
Private Equity Wire, Law.com International/Middle East and Africa, Reuters, Bloomberg Law, and ROI-NJ also cover Turman’s transition to Lowenstein. (subscription required to view certain content) View Lowenstein's news announcement about Turman joining the firm.
Lowenstein’s representation of independent private equity firm NexPhase Capital, LP in the sale of Insurance Technologies, LLC to private equity firm Thomas H. Lee Partners is noted in Business Wire, Cision PR Newswire, citybizlist, TheStreet, Bloomberg Law, and the Global Legal Chronicle. The Lowenstein deal team included Christopher C. Henry, Michael Walutes, Zarema A. Jaramillo, Doreen M. Edelman, Jack Sidorov, Megan Monson, Matthew Tippy, Amanda C. Lutick, and Michael T. Melchiorre. View Lowenstein's news announcement about this transaction.
In Bankrate, Ed Zimmerman and Meredith Beuchaw of Lowenstein Sandler’s Tech Group discuss 2020’s booming tech IPO market and SPAC trend. Contrasting the current IPO market with the over-hyped bubble, Adjunct Professor of Venture Capital at Columbia Business School and Lowenstein Sandler’s Tech Group Chair Zimmerman says: “The companies that we’re seeing going public in the tech world today are performing,” adding that SPACs may be more risky. “SPACs – what happens if they clock out before they can roll out a company? They may close deals, but they may catch falling knives to complete their mandate.”
Both lawyers anticipate an impact from the upcoming election. Zimmerman advises growth equity investors, VCs and management teams that are poised to IPO “to think carefully about the timeframe for their investments and how they might deal with fallout from November.” Beuchaw observes: “Companies are prepping for potential disruptions, even if they don’t come to pass….If capital dries up, that could lead companies to take an alternative path to get into the public markets…– IPOs, SPACs.” She says, “They’re dual-tracking an entry into public markets, perhaps through a merger or acquisition.”
Lowenstein's representation of Traub Capital, an investment firm specializing in building value in consumer companies using its unique combination of strategic, operational, and financial expertise, in the company’s purchase of MANA Products, a premier beauty contract manufacturer based in Long Island City, New York, is noted in the Global Legal Chronicle. The Lowenstein deal team included Michael A. Brosse, Lauren M. Troeller, Lowell A. Citron, Doreen M. Edelman, Darren Goodman, Ted Hunter, Marc S. Kurzweil, Gavin J. Rooney, Jeffrey M. Shapiro, Michael Walutes, James C. Shehan, Norman W. Spindel, Daniel A. Suckerman, David Toma, Stuart S. Yusem, Abbey E. Baker, Eric Jesse, Stacey C. Tyler, Naomi D. Barrowclough, Matthew P. Hintz, Manali Joglekar, Kimberly E. Lomot, Kathleen A. McGee, Megan Monson, Zachary L. Berliner, Christian C. Contardo, Mark S. Heinzelmann, Amanda C. Lutick, Michael T. Melchiorre, Joshua A. Rabinovits, Stephen Tanico, Jenna-Marie Tracy, Joseph Mignone, and Keith Janowitz. View Lowenstein's news announcement about this transaction.
Law.com reports that mergers and acquisitions attorney Meredith Beuchaw has joined Lowenstein Sandler’s Tech Group as partner, noting that “[w]hile laterals for certain practice groups, such as life sciences and bankruptcy and restructuring, have been quite active during the pandemic, M&A attorney pickups have been less common.” Beuchaw says, “Joining the Tech Group provides the opportunity to participate in a community of lawyers who are renowned for their creative and strategic approaches to uniting visionaries and funders.” The article goes on to note that the firm “has seen significant growth in revenue and head count over the past decade ... [and has] increased revenue by a whopping 43% from its 2011 numbers.”
Beuchaw's arrival to Lowenstein is also noted in Bloomberg Law, General Counsel News, and Westlaw Today. View Lowenstein's news announcement about Beuchaw joining the firm.
Lowenstein's representation of Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) in entering into a definitive share exchange agreement with F-star Therapeutics Limited to acquire all of the outstanding share capital of F-star in exchange for newly issued shares of Spring Bank in an all-stock transaction is highlighted in the Global Legal Chronicle. The Lowenstein deal team included John D. “Jack” Hogoboom, Daniel C. Porco, and Madeline Roe (Corporate); Brian A. Silikovitz and Kristin V. Taylor (Tax); Robert J. Paradiso (Patent Counseling & Prosecution); and Andrew E. Graw and Christine Osvald-Mruz (Executive Benefits & Executive Compensation). View Lowenstein's news announcement about this transaction.
Lowenstein represented both Serial Productions and “This American Life” in a pair of simultaneous deals with The New York Times Company (which acquired Serial and struck a strategic alliance with “This American Life”) as noted in The New York Times, The Wall Street Journal, MarketWatch, citybizlist, Variety, finanzen.net, and Global Legal Chronicle among others. Lowenstein’s deal team included Ed Zimmerman, Anthony W. Raymundo, and Matt Savare. View Lowenstein's news announcement about these transactions.
Lowenstein’s representation of Spring Bank Pharmaceuticals, Inc. in its definitive share exchange agreement with F-star to combine as F-star Therapeutics, Inc. is reported in Canada Stock Watch. The Lowenstein deal team included John D. “Jack” Hogoboom, Daniel C. Porco, and Madeline Roe (Corporate); Brian A. Silikovitz and Kristin V. Taylor (Tax); Robert J. Paradiso (Patent Counseling & Prosecution); and Andrew E. Graw and Christine Osvald-Mruz (Executive Benefits & Executive Compensation). View Lowenstein's news announcement about this transaction.
Lowenstein's representation of InSite Wireless Group, LLC (InSite), one of the largest privately owned tower and wireless infrastructure companies in the United States, in the acquisition of Repeater Communications Group, LLC, is highlighted in The Deal, the Global Legal Chronicle and Cision PR Newswire. The Lowenstein deal team included Michael A. Brosse, Nicole Rae Morales, and Michael Walutes. View Lowenstein's news announcement about this transaction.
The Deal reports on the acquisition by Lowenstein client InSite Wireless Group, LLC, one of the largest privately owned tower and wireless infrastructure companies in the United States, in the acquisition of Repeater Communications Group. The Lowenstein deal team included Michael A. Brosse, Nicole Rae Morales, and Michael Walutes. View Lowenstein's news announcement about this transaction.
The Deal notes that Steven E. Siesser and Traci M. Tomaselli of Lowenstein Sandler represented the management of HealthPlanOne, a digital distributor of health insurance products, in a transaction in which Lightyear Capital will purchase a majority stake in the company from Peloton Equity and other investors. The Associated Press, PE Hub, The Daily Times, Business Wire, and the Global Legal Chronicle, and other media outlets also reported the recapitalization. In addition to Siesser and Tomaselli, the deal team includes James E. Gregory, Lesley P. Adamo, and Taryn E. Cannataro.
Citybizlist, Marketwatch, GlobeNewswire, M&A Navigator, MassDevice.com, the Global Legal Chronicle, Law360, and MD and DI Online report the sale of Lowenstein client Artegraft to LeMaitre Vascular for $90 million. The Lowenstein deal team includes Michael J. Lerner, Michael Reinhardt, Annie Nazarian Davydov, Darren Goodman, Robert J. Paradiso, Mary E. Storella, Brian A. Silikovitz, Sophia Mokotoff, James C. Shehan, Norman W. Spindel, Taryn E. Cannataro, Danielle M. Falzone, and Jesse S. O’Connell. (subscription required to access certain content) View Lowenstein's news announcement about this transaction.
Lowenstein's representation of issuer Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) in connection with the company’s approximately $150 million public offering of common stock is highlighted in the Global Legal Chronicle. The Lowenstein team included Anthony O. Pergola, Alan Wovsaniker, Kate Basmagian, Alexander Dinur, Madeline Roe, Sarah Gore, and Robert J. Paradiso. View Lowenstein's news announcement about this transaction.
ROI-NJ, citybizlist, S&P Global, InvestorsHub, MarketScreener.com, and the Global Legal Chronicle report that Lowenstein client DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, will acquire Adgero Biopharmaceuticals Holdings, Inc., a privately held biopharmaceutical company focused on the development of its late stage photodynamic therapy platform for the treatment of serious cutaneous oncology indications. The Lowenstein deal team includes Michael J. Lerner, Steven M. Skolnick, Alan Wovsaniker, Kate Basmagian, Robert Bee, Justin Gindi, and Erica Perlmutter. View Lowenstein's news announcement about this transaction.
Steven E. Siesser speaks with PE Hub on the increase in PIPES deals as distressed publicly traded companies seek cash and private equity firms see investment opportunities. Private equity firms, through PIPE investments, can provide much-needed liquidity to companies suffering liquidity issues and help stave off restructuring and/or bankruptcy. (subscription required to access article)
NJBIZ mentions Kimberly E. Lomot and Jesse S. O’Connell in an article about small businesses and nonprofits seeking help with applying for government relief in the wake of the COVID-19 pandemic. Julie Murphy, executive director of Partners for Women and Justice, an organization that provides legal assistance to survivors of domestic violence, sought pro bono advice about the Paycheck Protection Program. Lomot and O’Connell answered her questions about the application and connected her to Northeast Bank, facilitating a smooth and successful loan process. The loan, most of which will be forgiven, will help keep this critical organization in operation throughout the pandemic.
The arrival to Lowenstein of senior counsel Mary E. Storella as Vice Chair of the Life Sciences group and head of Life Sciences Transactions is highlighted in NJBIZ, Private Equity Wire, Law.com (New Jersey Law Journal), Bloomberg Law, Mergers & Acquisitions, and The Deal. View Lowenstein's news announcement about Storella joining the firm.
Lowenstein's representation of Veronis Suhler Stevenson in the completion of its investment (with NewSpring Health Capital) in the BRC Recovery Family of Programs is noted in the Global Legal Chronicle. The Lowenstein deal team included Steven E. Siesser, Eileen Overbaugh, Traci M. Tomaselli, Brooke A. Gillar, and Lesley P. Adamo. View Lowenstein's news announcement about this transaction.
Lowenstein's representation of Computershare Limited in entering into a binding agreement to acquire the business and assets of Corporate Creations Enterprises LLC is noted in the Global Legal Chronicle. The Lowenstein team included Jonathan C. Wishnia, Eric Swartz, Bianka V. Barraza, Madeline Roe, Brian A. Silikovitz, Kristin V. Taylor, Julie Levinson Werner, Megan Monson, Taryn E. Cannataro, Stuart S. Yusem, Bryan Sterba, Jenna-Marie Tracy, Matthew P. Hintz, Matthew M. Oliver, Michael T. G. Long, Michael C. Townsend, and Eric Jesse.
PE Hub, Opalesque, Markets Media, MarketScreener.com, TMCNet.com, and the Global Legal Chronicle note Lowenstein Sandler’s representation of ACA Compliance Group, a leading global provider of governance, risk, and compliance advisory services and technology solutions, in the sale of its NorthPoint product suite and technology consulting practice to Credit Suisse Asset Management's NEXT Investors, a leading fintech growth equity group. The Lowenstein deal team included Michael A. Brosse, Eric Swartz, Michael T. Melchiorre, Michael Walutes, Nicholas G. Mehler, Megan Monson, and Taryn E. Cannataro. (subscription required to view certain content) View Lowenstein's news announcement about this transaction.
Lowenstein’s representation of Timber Pharmaceuticals in its definitive merger agreement with BioPharmX Corporation was noted in citybizlist, ROI-NJ, BioWorld, and Cision PR Newswire. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Alexander Dinur, and Tracy F. Buffer. View Lowenstein's news announcement about this transaction.
Lowenstein’s role representing independent private equity firm NexPhase Capital, LP in its newly announced strategic partnership with DealerOn, Inc., a leading website and digital marketing company serving the retail automotive industry, was mentioned in citybizlist, Automotive News, The Banks Report, Cision PR Newswire, and AutoSuccess. The Lowenstein deal team included Christopher C. Henry, Andrew P. Erdmann, Alexander Brooks, Matt Savare, Theodore C. Sica, Michael Walutes, Julie Levinson Werner, Eric Jesse, Megan Monson, Bianka V. Barraza, Chelsea P. Ferrette, Carly S. Penner, Bryan Sterba, Matthew Tippy, Vikram Paul, and Serena Ward. View Lowenstein's news announcement about this transaction.
Lowenstein’s representation of Thames Valley Communications (TVC) in its acquisition by Atlantic Broadband is noted in Light Reading, Telecompaper, citybizlist, Global Legal Chronicle, and Business Wire. TVC is a broadband services company operating in Southeastern Connecticut. Atlantic Broadband, a subsidiary of Cogeco Communications Inc. (TSX: CCA), is the eighth-largest cable operator in the United States. The Lowenstein deal team included Michael A. Brosse, Eugene R. Cheval, Claudia Lorenzo, Michael Walutes, and Megan Monson.
Lowenstein's representation of PVH Corp. [NYSE:PVH] in its definitive agreement to sell its Speedo North America business to Pentland Group for $170 million in cash is highlighted in Law360, Bloomberg Law, Retail Dive, Financial News, and the Global Legal Chronicle. The Lowenstein deal team included Marita A. Makinen, Andrew P. Erdmann, Doreen M. Edelman, Andrew E. Graw, Darren Goodman, Mary J. Hildebrand, Matt Savare, Michael Walutes, Jeffrey M. Shapiro, Jack Sidorov, Abbey E. Baker, Manali Joglekar, Justin Gindi, Sophia Mokotoff, Nicole Rae Morales, Bryan Sterba, and Vikram Paul. The PVH team included Mark Fischer, Jeffrey Hellman, and Meredith Felz (Legal), along with Dana Perlman and Lina Yoo (In-house Deal Makers). (subscription required to access certain content) View Lowenstein's news announcement about this transaction.
Ed Zimmerman’s comments are featured in The New York Times, Reuters, Deal Street Asia, and Business News World in an article on market conditions for mergers, acquisitions, and financing for late-stage startups and tech growth companies in the wake of WeWork’s failed IPO. Zimmerman, Chair of Lowenstein’s Tech Group, observes that overfunded growth companies could clog the market for venture-backed M&A: "How do you buy a company with $400 million or $800 million of liquidation preference for under a billion dollars?” (subscription required to access The New York Times article)
Lowenstein’s role representing Arotech Corporation (ARTX) in its agreement to be acquired for approximately $80.8 million is mentioned in The Deal, Law360 (September 23, 2019; September 27, 2019), the Global Legal Chronicle, GlobeNewswire, Crain's Detroit Business, Yahoo Finance, and Nasdaq. The Lowenstein deal team included Steven M. Skolnick, Alan Wovsaniker, Kate Basmagian, Elisia M. Klinka, and Mitchell McDonald. (subscription required to access certain content) View Lowenstein's news announcement about this transaction.
Lowenstein's representation of Crimson Investment, a global private equity firm headquartered in San Francisco, in the sale of Milton Industries, Inc. to Levine Leichtman Capital Partners, a Los Angeles-based private equity firm, is highlighted in the Global Legal Chronicle. The Lowenstein deal team included Christopher C. Henry, Theodore C. Sica, Brian A. Silikovitz, Mark S. Heinzelmann, Lauren E. Killeen, Sophia Mokotoff, Megan Monson, Nick Samedi, and Jacob D. Unger. View Lowenstein's news announcement about this transaction.
Lowenstein's representation of The Estée Lauder Companies Inc. in its acquisition of the shares that the company does not already beneficially own in Have & Be Co. Ltd., the Seoul-based, global skin care company behind Dr. Jart+ and men’s grooming brand Do The Right Thing, is noted in Mergers & Acquisitions, Yahoo! Finance, Digital Commerce 360, PYMNTS.com, the Global Legal Chronicle, The Deal (article; deal listing), Law360, Business Wire, Bloomberg, and The Beauty Influencers. Led by partner Marita A. Makinen, the Lowenstein deal team includes Gina M. Seong, Darren Goodman, Doreen M. Edelman, Mary J. Hildebrand, Matt Savare, Michael Walutes, Jack Sidorov, Abbey E. Baker, Kate Basmagian, Manali Joglekar, Taryn E. Cannataro, Sophia Mokotoff, Carly S. Penner, Bryan Sterba, and Matthew Tippy. (subscription required to access article) View Lowenstein's news announcement about this transaction.
Lowenstein's representation of MKG, Pink Sparrow, and Maneesh K. Goyal, the founder and chairman of both companies, in those entities’ acquisition by Acceleration Community of Companies is noted in The Hollywood Reporter, Business Wire, the Valdosta Daily Times, the Global Legal Chronicle, PR Week and citybizlist. The Lowenstein deal team included Steven E. Siesser, Traci M. Tomaselli, Lesley P. Adamo, Nicole Stefanelli, Madeline Roe, Sophia Mokotoff, and Megan Monson.
Lowenstein's representation of W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the health care sector, in the acquisition of Arcus Medica, a recognized leader in medical and scientific communications, highlighted in the Global Legal Chronicle. The Lowenstein deal team included David L. Goret, Marita A. Makinen, Andrew P. Erdmann, Matthew Tippy, Eugene R. Cheval, Tracy F. Buffer, Michael Walutes, Sophia Mokotoff, Megan Monson, Matt Savare, Bryan Sterba, Mary J. Hildebrand, Manali Joglekar, Carly S. Penner, Amy Komoroski Wiwi, and James C. Shehan. View Lowenstein's news announcement about this transaction.
Lowenstein’s representation of NexPhase Capital in its investment in Popcornopolis was reported in Business Wire, the Valdosta Daily Times, Bloomberg Law – Big Law Business, The Tullahoma Tennessee News, Mergers & Acquisitions, and the Global Legal Chronicle. The Lowenstein team included Christopher C. Henry, Michael Walutes, Matt Savare, Vanessa A. Ignacio, Julie Levinson Werner, James C. Shehan, Eric Jesse, Sabrina Cua, Bryan Sterba, Megan Monson, and Lauren M. Troeller. View Lowenstein's news announcement about this transaction.
Lowenstein’s role in the merger agreement between firm client Sonnet BioTherapeutics and Chanticleer Holdings is mentioned in Proactive Investors USA & Canada, ROI-NJ, citybizlist, GlobeNewswire, and the Global Legal Chronicle. The Lowenstein deal team included Steven M. Skolnick, Sarah P. Cole, and Tracy F. Buffer.
Steven S. Rogers' arrival at Lowenstein as a partner in the Transactions & Advisory Group is noted in Bloomberg Law – Big Law Business.
Lowenstein Sandler’s representation of Thailand’s leading global chemical company, Indorama Ventures (IVL), in its $2.1 billion acquisition of Huntsman’s chemicals units was featured in numerous media outlets including The Wall Street Journal and The Deal, which highlighted Nicholas San Filippo IV’s role in the transaction and previous work with IVL since 2003. The Nation Thailand called the transaction “a game changing acquisition for IVL, its largest ever and one of the biggest by a Thai company in the last decade.” The acquisition was also featured Bloomberg Law – Big Law Business, The Deal, The Associated Press, the Global Legal Chronicle, Business Wire, citybizlist, Bakersfield.com, The American Lawyer, and Law360. The Lowenstein Sandler deal team included Nicholas San Filippo IV, Sam E. Khan, Stuart S. Yusem, Nicholas G. Mehler, Christine Osvald-Mruz, Doreen M. Edelman, Brian Silikovitz, Norman W. Spindel, Mark S. Heinzelmann, Mitchell McDonald, Megan Monson, Sami Najib, Sunita Patel, Alex H.Rosenthal, and Niral T. Shah. The Valence Group acted as exclusive financial adviser to IVL, and KPMG provided financial due diligence support. (subscription required to access certain content) View Lowenstein's news announcement about this transaction.
Longtime firm client Tower International's (NYSE: TOWR) acquisition by private equity-owned Autokiniton Global Group, in a $900 million deal expected to close in September or October, is reported in Crain's Detroit Business, The PE Hub Network, Automotive News, InvestorsHub, Law360, Smart Business Dealmakers, Mergers & Acquisitions, and the Global Legal Chronicle. (Lowenstein deal team: Peter H. Ehrenberg, Andrew E. Graw, Lowell A. Citron, Marita A. Makinen, Jeffrey Blumenfeld, Jack Sidorov, Jeffrey M. Shapiro, Elisia M. Klinka, Justin Gindi, Kate Basmagian, Daniel C. Porco, Matthew A. Weston, Erica Perlmutter, Robert Bee, Sabrina Cua, Brian A. Silikovitz, Kristin V. Taylor, Katie R. Glynn, Nicholas G. Mehler, Doreen M. Edelman, Lynda A. Bennett, Megan Monson, Michael B. Himmel, and Norman W. Spindel) View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler’s role as legal counsel to Aceto Corporation in its Chapter 11 bankruptcy filing and in the proposed $338 million sale of its chemical business assets to New Mountain Capital is highlighted in Bankrupt Company News, MarketWatch, GlobeNewswire, Markets Insider, StreetInsider.com, EIN Presswire, MarketScreener.com, and the Global Legal Chronicle (May 20, 2019; June 22, 2019). The firm’s role as legal counsel in Aceto’s sale of subsidiary Rising Pharmaceuticals, Inc. is noted in The Associated Press, MarketScreener.com, and the Global Legal Chronicle. (Lowenstein team: Kenneth A. Rosen, Steven E. Siesser, Paul Kizel, Michael S. Etkin, Jeffrey Cohen, Wojciech F. Jung, Philip J. Gross, Michael Savetsky, and Michael Papandrea.) (subscription required to view certain content) View Lowenstein’s news announcements about this representation: March 18, 2019; May 13, 2019.
Morningstar Inc., Yahoo Finance, BioSpace, Cision PR Newswire, Chain Drug Review, and the Global Legal Chronicle note Lowenstein Sandler as counsel to Crown Laboratories, Inc. and Hildred Capital Partners LLC in Crown’s acquisition of the North American distribution rights to Keri from GlaxoSmithKline plc (NYSE: GSK). (Lowenstein deal team: Herschel S. Weinstein, Sam E. Khan, Mitchell McDonald, James C. Shehan, Matthew P. Hintz, Michael A. Buxbaum, Matthew Tippy, Erica Perlmutter, Jeffrey M. Shapiro, and Jack Sidorov.) View Lowenstein’s news announcement about this transaction.
Mondaq News, Retail Dive, The PE Hub Network, StreetInsider.com, and the Global Legal Chronicle cover news of Lowenstein client Ethoca’s acquisition by Mastercard. (The Lowenstein deal team included: Steven E. Siesser, Traci M. Tomaselli, Anthony O. Pergola, Lesley P. Adamo, Jeffrey Blumenfeld, Jeffrey M. Shapiro, Jack Sidorov, Michael J. Mueller, Darren Goodman, Megan Monson, Gina M. Seong, James McDonough, Sophia Mokotoff, Erica Perlmutter, and Lauren Killeen.) View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler’s role as legal counsel to Medalist Partners, LP in its acquisition of a majority stake in JMP Credit Advisors LLC was mentioned in SCNow, Finger Lakes Times, The Financial Times, Business Wire, Bakersfield.com, MarketScreener.com, and the Global Legal Chronicle. (Lowenstein deal team: Edward S. Nadel, Christopher C. Henry, Jonathan C. Wishnia, Julie Levinson Werner, and Robert J. Menendez). View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler’s representation of Abry Partners in its convertible preferred equity investment in PowerFleet, Inc., the new global IoT company to be formed by the acquisition of Pointer Telocation Ltd. by I.D. Systems, Inc., was mentioned in ROI-NJ, Law360, The PE Hub Network, StreetInsider.com and the Global Legal Chronicle. (Lowenstein deal team: Steven E. Siesser, Brooke A. Gillar, Kate Basmagian, and Matthew A. Weston.) View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler’s role as legal counsel to New Mountain Capital and portfolio company Topix Pharmaceuticals, Inc. in connection with the acquisition by Topix of ClarityRx Clinical Skin Care, Inc. is highlighted in The PE Hub Network, Business Wire, the San Fernando Valley Business Journal, Cosmetics Technology, and the Global Legal Chronicle. (Lowenstein deal team: Marita A. Makinen, David L. Goret, Michael Walutes, Matt Savare, Vanessa A. Ignacio, Anthony W. Raymundo, Megan Monson, Bryan Sterba, and Jacob D. Unger.) View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler’s role as legal counsel to Aceto Corporation in its Chapter 11 bankruptcy filing and in the proposed $338 million sale of its chemical business assets to New Mountain Capital is highlighted in Bankrupt Company News, MarketWatch, GlobeNewswire, Markets Insider, StreetInsider.com, and EIN Presswire. The firm’s role as legal counsel in Aceto’s sale of subsidiary Rising Pharmaceuticals, Inc. is noted in The Associated Press and MarketScreener.com. (Lowenstein team: Kenneth A. Rosen, Steven E. Siesser, Paul Kizel, Michael S. Etkin, Jeffrey Cohen, Wojciech F. Jung, Philip J. Gross, Michael Savetsky, and Michael Papandrea.) (subscription required to view certain content) View Lowenstein’s news announcement about this transaction.
The PE Hub Network, The Deal, and Law360 (December 12, 2018; January 24, 2019) note Lowenstein Sandler as lead counsel to Cerberus Capital Management, L.P. in its acquisition of Sparton Corporation (NYSE: SPA). (Lowenstein deal team: Marita A. Makinen, Robert G. Minion, Jeffrey Blumenfeld, Mary J. Hildebrand, Nicholas G. Mehler, Christine Osvald-Mruz, Matt Savare, Jeffrey M. Shapiro, James C. Shehan, Michael Walutes, Jack Sidorov, Norman W. Spindel, Stuart S. Yusem, Manali Joglekar, Sabrina Cua, Allison Gabala, Megan Monson, Alex H. Rosenthal, Bryan Sterba, Matthew Tippy, Lauren E. Killeen, and Lauren M. Troeller.) (subscription required to view certain content) View Lowenstein’s news announcement about this transaction.
Lowenstein Sandler is noted as lead counsel to Vesey Street Capital Partners, LLC (VSCP) in their recapitalization of Elite Body Sculpture as published in The PE Hub Network, Cision PR Newswire, and The Business Journals (Lowenstein deal team: Marc B. Kramer, Brooke A. Gillar, Steven E. Siesser, Lowell A. Citron, Michael Walutes, Lesley P. Adamo, Eileen Overbaugh, Elisia M. Klinka, Nicholas Gonski, Darren Goodman, Megan Monson, Eric Jesse, Alanna Sandoval, Jeffrey M. Shapiro, Jack Sidorov, Mark P. Kesslen, Paul M. Krueger, Michael A. Buxbaum, Norman W. Spindel, Mary J. Hildebrand, Bryan Sterba, Manali Joglekar, and Stuart S. Yusem.)
StreetInsider.com, The Deal, citybizlist, The PE Hub Network (October 15, 2018; December 18, 2018), MarketWatch, Law360, Global Legal Chronicle, and Business Wire note Lowenstein Sandler as counsel to Cambium Learning Group, Inc. in its $900 million definitive merger agreement with Veritas Capital. (Lowenstein deal team: Steven E. Siesser, Elisia M. Klinka, Brooke A. Gillar, Michael J. Mueller, Lauren M. Troeller, Bianka V. Barraza, Lowell A. Citron, Jeffrey Blumenfeld, Jack Sidorov, Jeffrey M. Shapiro, Steven M. Skolnick, Kate Basmagian, Scott Siegel, Lesley P. Adamo, Sophia Mokotoff, Darren Goodman, Megan Monson, Katie R. Glynn, David W. Field, Michael A. Kaplan, Eric Jesse, Nicholas G. Mehler, Steven M. Hecht, Sean Collier, Edward J. Hunter, Zarema A. Jaramillo, Andrew David Behlmann, and Gina M. Seong.) (subscription required to access certain content) View Lowenstein’s news announcement about this transaction.
MarketWatch, GlobeNewswire, TenLinks, StreetInsider.com, Yahoo! Finance, Digital Engineering, Global Legal Chronicle, and Crain's Detroit Business note Lowenstein Sandler as counsel to Altair Engineering Inc. (Nasdaq: ALTR) in its $176 million acquisition of Datawatch Corporation (Nasdaq: DWCH). (Lowenstein deal team: Peter H. Ehrenberg, Michael J. Mueller, Elizabeth A. Mandle, Justin Gindi, Colin J. Kirby, Valeska Pederson Hintz, Kate Basmagian, Lauren E. Killeen, Darren Goodman, Megan Monson, Brian A. Silikovitz, Sophia Mokotoff, Mark P. Kesslen, Manali Joglekar, Leah Satlin, Jeffrey Blumenfeld, Jack Sidorov, Jeffrey M. Shapiro, Lynda A. Bennett, Eric Jesse, Lowell A. Citron, Lauren M. Troeller, and Erica Perlmutter.) View Lowenstein’s news announcement about this transaction.
Business Wire, MarketWatch, Pharmaceutical Business Review, Cosmetics Technology, ABF Journal, Cision PR Newswire, and the Tullahoma News note Lowenstein Sandler as counsel to Crown Laboratories, Inc. (Crown Laboratories) and Hildred Capital Partners, LLC in Crown Laboratories’ acquisition of the North American distribution rights of five OTC consumer brands from GlaxoSmithKline plc (NYSE: GSK). (Lowenstein deal team: Herschel S. Weinstein, Sam E. Khan, Mitchell McDonald, Sunita Patel, James C. Shehan, Matthew P. Hintz, Sofia Kopelevich, Michael A. Buxbaum, Nicholas Gonski, Matthew Tippy, Jeffrey M. Shapiro, and Jack Sidorov. View Lowenstein’s news announcement about this transaction.
Reuters, Axios, The PE Hub Network, Food Processing Technology (October 31, 2018; November 2, 2018), Global Legal Chronicle, and just-food.com note Lowenstein Sandler as counsel to Traub Capital LLC in its acquisition of Signature Brands from The Hero Group. (Lowenstein deal team: Michael A. Brosse, Michael J. Mueller, Sabrina Cua, Justin Gindi, Lowell A. Citron, Theodore C. Sica, Nicholas Gonski, Michael Walutes, Nicholas G. Mehler, Matthew P. Hintz, Sofia Kopelevich, Darren Goodman, Megan Monson, Eric Jesse, James C. Shehan, Stuart S. Yusem, and Mitchell McDonald.) View Lowenstein’s news announcement about this transaction.
StreetInsider.com, MarketWatch, RTTNews, The Advocate, Markets Insider, and Seeking Alpha highlight Lowenstein client Compassionate Care Hospice’s entering a definitive agreement to be acquired by Amedisys, Inc. (Lowenstein deal team: Marita A. Makinen, Annie Nazarian Davydov, James C. Shehan, Michael Walutes, Michael N. Gooen, Darren Goodman, Sophia Mokotoff, Jack Sidorov, and Scott Siegel.) View Lowenstein’s news announcement about this transaction.
Business Wire, Compelo Ltd., and citybizlist note Lowenstein Sandler as legal counsel to Crown Laboratories, Inc. and Hildred Capital Partners, LLC in Crown's acquisition of Bellus Medical, which will become the new Aesthetics Division of Crown Laboratories. (Lowenstein deal team led by Sam E. Khan and Herschel S. Weinstein.)
Capacity Media,The PE Hub Network, Fiber Optics Online, TMCNet.com, PR Newswire (May 30, 2018; September 4, 2018), and TeleGeography note Lowenstein Sandler’s representation of Hudson Fiber Network, portfolio company of Tiger Infrastructure Partners, in its all-cash merger agreement with ExteNet Systems, Inc. (Lowenstein deal team: Michael A. Brosse, Eric Swartz, Justin Gindi, David Leit, Michael Walutes, Megan Monson, Darren Goodman, Alexandra S. Droz, Eric Jesse, Lesley P. Adamo, and Marc S. Kurzweil.)
In an article noting that Massachusetts-based companies accounted for nearly half of all 2017 biotech industry investments, BioPharma-Reporter reprints a quote from Steven M. Skolnick, who stated in the publication’s August 20, 2018, article that a strong market and economy have been drivers behind investments and M&A activity, leading to a large number of successful biotech IPOs.
MarketWatch, NJBIZ, ROI, Nasdaq, American Banker, City Biz List, Forex TV.com, and the Commerce and Industry Association of New Jersey’s (CIANJ) Business Beat newsletter note Lowenstein Sandler is representing Lakeland Bancorp, Inc., in its acquisition of Highlands Bancorp, Inc., in a transaction valued at approximately $56 million. (subscription required to access certain content)
Steven M. Skolnick is extensively quoted in BioPharma-Reporter regarding potentially record-breaking numbers in biotech initial public offerings in 2018. Skolnick notes the strong market and economy are drivers behind investments and M&A activity, leading to a large number of successful biotech IPOs. While the first half of 2018 started off strong, Skolnick cautions that the political climate and normal market indicators may cause volatility in the latter half of the year.
The Global Legal Chronicle notes Lowenstein Sandler's representation of Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. The write-up lists the Lowenstein team: Steven E. Siesser, Lowell A. Citron, Brooke A. Gillar, Lesley P. Adamo, Eric Jesse, Alexander Brooks, Sophia Mokotoff, Megan Monson, Matthew A. Nemeth, and Sami Najib. View Lowenstein’s news announcement about this transaction.
The PE Hub Network, Cision PR Newswire, and FierceBiotech note Lowenstein Sandler as counsel to Regulatory Professionals, Inc. (RPI) in its acquisition by Premier Research. View Lowenstein’s news announcement about this transaction.
The PE Hub Network and Mergers & Acquisitions note Lowenstein Sandler as counsel to NexPhase Capital, LP in its equity stake investment in Brandt Information Services, LLC.
The Global Legal Chronicle notes Lowenstein Sandler’s representation of Integral Ad Science in an article discussing Vista Equity Partners’ majority-stake acquisition of the company. The article notes that the Lowenstein deal team was led by Raymond P. Thek and included Peter H. Ehrenberg, Ed Zimmerman, Colin J. Kirby, Shimite Obialo, Sarah Gore, Elias Kwon, Alex Galev, Christina Lee, and Kristen Nicol, as well as support from specialists in Tax: Brian A. Silikovitz and Sophia Mokotoff; Employee Benefits & Executive Compensation: James E. Gregory, Darren Goodman, Megan Monson, and Eric Margulies; Intellectual Property Litigation: Mark P. Kesslen and Lisa A. Harvey; Antitrust & Trade Regulation: Zarema A. Jaramillo; and Privacy & Cybersecurity: Mary J. Hildebrand. View Lowenstein’s news announcement about this transaction.
MarTech Series, Markets Insider, 4-traders.com, The PE Hub Network and citybizlist highlight Lowenstein Sandler as legal counsel to global software company Integral Ad Science in its majority-stake acquisition by leading private equity firm Vista Equity Partners.
4-traders.com and StreetInsider.com note Lowenstein Sandler as legal co-counsel with Gracin & Marlow, LLP to Aravive Biologics, Inc. in connection with its merger with a wholly owned subsidiary of Versartis, Inc. in an all-stock transaction. (Lowenstein deal team: Alan Wovsaniker and Andrew E. Graw.)
Cosmetics Technology and Business Wire note Lowenstein Sandler as legal counsel to New Mountain Capital and portfolio company Topix Pharmaceuticals, Inc., in their acquisition of DERMA E. (Lowenstein deal team: Marita A. Makinen, David L. Goret, Matt Savare, Michael Walutes, Darren Goodman, Eric Jesse, Manali Joglekar, Marc S. Kurzweil, Kimberly E. Lomot, Justin Gindi, Tim Janas, Megan Monson, Leah Satlin, and Jacob D. Unger.)
The PE Hub Network notes Lowenstein Sandler as legal counsel to Fenway Partners and affiliated investors in those entities' acquisition of Iconic Group.
Reorg Research, Chemical Engineering, and Textile World highlight Lowenstein as the legal advisor to Indorama Ventures Public Company Limited in its joint venture acquisition of M&G Chemicals’s Corpus Christi, Texas-based PTA-PET plant. Lowenstein is also listed as Indorama’s legal advisor in its acquisition of M&G Polimeros Brazil S.A., the largest PET facility in Brazil, by Textile World, Plastic News Europe, and Plastics in Packaging. (subscription required to access Reorg Research article)
Construction Business Owner highlights Lowenstein’s representation of Foley, Inc. in its acquisition of Ransome CAT.
Jeffrey M. Shapiro is quoted in Nasdaq regarding fledgling corporate spinoffs.
Nicholas San Filippo participates in Commerce Magazine's roundtable discussing M&A legal issues that are unique to family-owned businesses.
Brooke A. Gillar has been named among The M&A Advisor's "40 Under 40" in the Legal Advisor category. The M&A Advisor recognizes professionals under the age of 40 for their accomplishments and expertise in M&A, financing, and turnarounds.
Chapter 11 reorganization of New England Motor Freight (NEMF) named winner of “Restructuring of the Year ($25M to $50M)”
CLICK HERE FOR AWARD INFORMATION & METHODOLOGY
No aspect of this or any advertisement has been approved by the Supreme Court of California, the District of Columbia Court of Appeals, the Supreme Court of New Jersey, the New York State Court of Appeals, or the Utah Supreme Court.
